FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Betamethasone Dipropionate by Actavis Pharma, Inc., indicating an update to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis
• Psoriasis

Drugs mentioned

• BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

SUPPL AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)